Deficient IL-12p70 secretion by dendritic cells based on IL12B promoter genotype

Genes and Immunity

Volumn 5, Issue 5, 2004, Pages 431-434

  Müller Berghaus, Jan ^a,d   Kern, K ^a   Paschen, A ^a   Nguyen, X D ^b   Kluter H ^b   Morahan, G ^c   Schadendorf, D ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^d Dermato Onkologie   (Germany)

Author keywords

Cytokine; Interleukin 12; Polymorphism

Indexed keywords

CD40 LIGAND; INTERLEUKIN 12; PROTEIN P40; PROTEIN P70;

ARTICLE; ASTHMA; BRAIN MALARIA; CHILDHOOD DISEASE; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; DISEASE PREDISPOSITION; DISEASE SEVERITY; FATALITY; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOREGULATION; MOLECULAR DYNAMICS; NORMAL HUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN SECRETION; TH1 CELL;

ASTHMA; DENDRITIC CELLS; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERLEUKIN-12; INTERLEUKIN-12 SUBUNIT P40; MONOCYTES; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); PROTEIN SUBUNITS;

EID: 4344717893     PISSN: 14664879     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gene.6364102     Document Type: Article

References (21)

1. Wolf SF, Temple PA, Kobayashi M et al. Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J Immunol 1991; 146: 3074-3081.
2. Kalinski P, Vieira PL, Schuitemaker JH, de Jong EC, Kapsenberg ML. Prostaglandin E(2) is a selective inducer of interleukin-12 p40 (IL-12p40) production and an inhibitor of bioactive IL-12p70 heterodimer. Blood 2001; 97: 3466-3469.
3. Liu J, Cao S, Herman LM, Ma X. Differential regulation of interleukin (IL)-12 p35 and p40 gene expression and interferon (IFN)-{gamma}-primed IL-12 production by IFN regulatory factor 1. J Exp Med 2003; 198: 1265-1276.
4. Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 2003; 3: 133-146.
5. Ma X, Chow JM, Gri G et al. The interleukin 12 p40 gene promoter is primed by interferon gamma in monocytic cells. J Exp Med 1996; 183: 147-157.
6. Snijders A, Kalinski P, Hilkens CM, Kapsenberg ML. High-level IL-12 production by human dendritic cells requires two signals. Int Immunol 1998; 10: 1593-1598.
7. Hilkens CM, Kalinski P, de Boer M, Kapsenberg ML. Human dendritic cells require exogenous interleukin-12-inducing factors to direct the development of naive T-helper cells toward the Th1 phenotype. Blood 1997; 90: 1920-1926.
8. Cella M, Scheidegger D, Palmer-Lehmann K, Lane P, Lanzavecchia A, Alber G. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J Exp Med 1996; 184: 747-752.
9. Oppmann B, Lesley R, Blom B et al. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 2000; 13: 715-725.
10. Cua DJ, Sherlock J, Chen Y et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 2003; 421: 744-748.
11. Gillessen S, Carvajal D, Ling P et al. Mouse interleukin-12 (IL-12) p40 homodimer: a potent IL-12 antagonist. Eur J Immunol 1995; 25: 200-206.
12. Ling P, Gately MK, Gubler U et al. Human IL-12 p40 homodimer binds to the IL-12 receptor but does not mediate biologic activity. J Immunol 1995; 154: 116-127.
13. Holscher C, Atkinson RA, Arendse B et al. A protective and agonistic function of IL-12p40 in mycobacterial infection. J Immunol 2001; 167: 6957-6966.
14. Morahan G, Boutlis CS, Huang D et al. A promoter polymorphism in the gene encoding interleukin-12 p40 (IL12B) is associated with mortality from cerebral malaria and with reduced nitric oxide production. Genes Immunity 2002; 3: 414-418.
15. Morahan G, Huang D, Wu M et al. Association of IL12B promoter polymorphism with severity of atopic and non-atopic asthma in children. Lancet 2002; 360: 455-459.
16. Ebner S, Ratzinger G, Krosbacher B et al. Production of IL-12 by human monocyte-derived dendritic cells is optimal when the stimulus is given at the onset of maturation, and is further enhanced by IL-4. J Immunol 2001; 166: 633-641.
17. Seegers D, Zwiers A, Strober W, Pena AS, Bouma G. A TaqI polymorphism in the 3′UTR of the IL-12 p40 gene correlates with increased IL-12 secretion. Genes Immunity 2002; 3: 419-423.
18. Liu W, Wei H, Liang S, Zhang J, Sun R, Tian Z. A balanced expression of two chains of heterodimer protein, the human interleukin-12, improves high-level expression of the protein in CHO cells. Biochem Biophys Res Commun 2004; 313: 287-293.
19. Hoffmann TK, Meidenbauer N, Muller-Berghaus J, Storkus WJ, Whiteside TL. Proinflammatory cytokines and CD40 ligand enhance cross-presentation and cross-priming capability of human dendritic cells internalizing apoptotic cancer cells. J Immunother 2001; 24: 162-171.
20. Kalinski P, Vieira P, Schuitemaker JH, Cai Q, Kapsenberg M. Generation of human type 1- and type 2-polarized dendritic cells from peripheral blood. Methods Mol Biol 2003; 215: 427-436.
21. Hackstein H, Hofmann H, Bohnert A, Bein G. Definition of human interleukin-4 receptor alpha chain haplotypes and allelic association with atopy markers. Hum Immunol 1999; 60: 1119-1127.